KIT and intrahepatic cholangiocarcinoma: After acquiring a mutation in the tyrosine kinase receptor c-KIT (CD117), the interstitial cells of Cajal (ICC), which are located in the myenteric plexus in the gastrointestinal wall and serve as a pacemaker of the gut, lose normal growth control and result in tumour formation [1].